ASP Isotopes (NASDAQ:ASPI) Hits New 12-Month High - Here's Why

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $9.33 and last traded at $8.66, with a volume of 438929 shares changing hands. The stock had previously closed at $8.77.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a research note on Friday, October 4th. They set a "buy" rating and a $4.50 price objective for the company. Canaccord Genuity Group reiterated a "buy" rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th. Finally, HC Wainwright reduced their price objective on ASP Isotopes from $5.50 to $4.50 and set a "buy" rating on the stock in a research note on Wednesday, August 7th.

ASP Isotopes Trading Down 5.7 %

The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06. The business's 50-day simple moving average is $4.01 and its two-hundred day simple moving average is $3.59. The company has a market capitalization of $588.52 million, a PE ratio of -13.13 and a beta of 3.88.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last released its earnings results on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The business had revenue of $1.02 million during the quarter. On average, analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.

Institutional Investors Weigh In On ASP Isotopes

Institutional investors have recently modified their holdings of the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in shares of ASP Isotopes during the third quarter worth about $6,249,000. GSA Capital Partners LLP increased its holdings in shares of ASP Isotopes by 96.0% in the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company's stock valued at $2,143,000 after buying an additional 377,721 shares in the last quarter. Fiera Capital Corp acquired a new stake in shares of ASP Isotopes during the third quarter worth $723,000. Marshall Wace LLP raised its holdings in ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company's stock worth $1,668,000 after buying an additional 433,734 shares during the period. Finally, Renaissance Technologies LLC lifted its position in shares of ASP Isotopes by 5.7% in the 2nd quarter. Renaissance Technologies LLC now owns 171,800 shares of the company's stock valued at $526,000 after acquiring an additional 9,200 shares in the last quarter. Institutional investors own 16.80% of the company's stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.